Rhythm Biosciences Ltd has released a press release.
Rhythm Successfully Validates Key Biomarker
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Rhythm Biosciences Granted China Patent
- ColoSTAT - Test Development Update
- Appendix 4C
- Rhythm signs Alfred Hospital for ColoSTAT clinical trial
- Monash Health signed with first patients recruited
Later from Rhythm Biosciences
- Successful ISO13485 Surveillance Audit
- COVID-19 Update
- Placement & Rights Offer to raise approximately $6 million
- Non-renounceable rights issue Offer
- Addtl Clinical Trial Site Signed - First Patient Recruited
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences